低睾酮与血液透析男性的衰弱、肌肉消耗及躯体功能障碍相关:一项纵向分析
本研究纳入440名血液透析男性,随访12个月,评估游离睾酮与衰弱(Fried表型)、肌少症、下肢功能及肌肉量的关联。结果显示,游离睾酮降低50%与衰弱、肌少症及肌肉量下降的 odds 升高相关,关联主要由握力和步速驱动。睾酮替代可能成为预防衰弱的潜在靶点,但需临床试验验证。
要点
- 游离睾酮降低50%与衰弱 odds 升高40%相关(OR 1.40,95%CI 1.05-1.53)。
- 游离睾酮降低50%与肌少症 odds 升高55%相关(OR 1.55,95%CI 1.09-2.02)。
- 关联主要由握力和步速两个衰弱组分驱动,并伴肌肉量下降。
核心结论
- 血清游离睾酮浓度与血液透析男性的衰弱、躯体功能、肌少症及肌肉量及其12个月变化相关。
- 睾酮替代可能是预防衰弱的可行治疗靶点,但需临床试验验证。
研究设计与样本
- 纵向分析,数据来自A Cohort Study To Investigate the Value of Exercise in ESRD/Analysis Designed to Investigate the Paradox of Obesity and Survival in ESRD研究。
- 纳入440名男性,来自美国亚特兰大和旧金山湾区14个透析中心,招募时间2009至2011年。
- 使用Fried衰弱表型评估衰弱,采用广义估计方程分析游离睾酮(连续和二分变量)与12个月内衰弱、衰弱组分、肌少症、下肢功能及肌肉量估计的关联。
主要发现
- 平均年龄56.1±14.2岁,27%为白人。
- 游离睾酮浓度降低50%与衰弱 odds 升高40%相关(OR 1.40,95%CI 1.05-1.53),与12个月内新发衰弱 odds 升高40%相关(OR 1.40,95%CI 1.07-1.73)。
- 关联主要归因于衰弱两个组分:握力和步速。
- 游离睾酮降低50%与肌少症 odds 升高55%相关(OR 1.55,95%CI 1.09-2.02),与新发肌少症 odds 升高72%相关(OR 1.72,95%CI 1.13-2.33)。
- 游离睾酮降低50%还与较低肌肉量及12个月内肌肉量下降相关,肌肉量通过血清肌酐和生物电阻抗谱估计。
临床怎么用
- 在血液透析男性中,可关注低游离睾酮作为衰弱、肌少症和躯体功能下降的风险标记。
- 睾酮替代作为预防衰弱的干预措施尚需临床试验验证,目前不应常规推荐。
局限性
- 原文未明确报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite the high prevalence of frailty among patients receiving hemodialysis, few preventable or treatable contributing causes have been identified. Hypogonadism is also common in this population and low serum testosterone concentrations share several clinical phenotypes with frailty. We hypothesized that low serum testosterone concentrations would be associated with frailty and several of its individual components. METHODS: We used data from 440 men from A Cohort Study To Investigate the Value of Exercise in ESRD/Analysis Designed to Investigate the Paradox of Obesity and Survival in ESRD, a longitudinal study that recruited participants from 14 dialysis centers in Atlanta, GA and the San Francisco, CA Bay Area from 2009 to 2011. We assessed frailty using the Fried Frailty Phenotype. We examined the association between free testosterone (as a continuous and dichotomous variable) and frailty, individual frailty components, sarcopenia, lower extremity function and muscle mass estimation by creatinine and body impedance spectroscopy over 12 months using generalized estimating equations. RESULTS: The mean age was 56.1 ± 14.2 years and 27% were white. A 50% lower concentration of free testosterone was associated with 1.40-fold higher odds of being frail [95% confidence interval (CI) 1.05-1.53] and 1.40-fold higher odds of becoming frail over 12 months (95% CI 1.07-1.73). This association was mainly due to an association with two components of frailty: grip strength and gait speed. In addition, 50% lower free testosterone concentration was associated with a 1.55-fold higher odds of having sarcopenia (95% CI 1.09-2.02) and 1.72-fold higher odds for developing sarcopenia (95% CI 1.13-2.33) as well as with lower muscle mass and a decrease in muscle mass over 12 months as estimated by serum creatinine and by bioelectrical impedance spectroscopy. CONCLUSION: Serum free testosterone concentration was associated with frailty, physical function, sarcopenia and muscle mass as well as with changes in these outcomes over 12 months. Testosterone replacement may be a feasible therapeutic target toward prevention of frailty, although clinical trials are needed to test this possibility.
引用
- Chiang JM, Kaysen GA, Segal M, et al. Low testosterone is associated with frailty, muscle wasting and physical dysfunction among men receiving hemodialysis: a longitudinal analysis. Nephrol Dial Transplant. 2019. PMID: 30085235. doi:10.1093/ndt/gfy252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。